Cargando…

Comment on “Vasoplegic syndrome following cardiothoracic surgery-review of pathophysiology and update of treatment options”

Detalles Bibliográficos
Autores principales:	Ortoleva, Jamel, Cobey, Frederick C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140332/ https://www.ncbi.nlm.nih.gov/pubmed/32264932 http://dx.doi.org/10.1186/s13054-020-02854-1

Ejemplares similares

Vasoplegic syndrome following cardiothoracic surgery—review of pathophysiology and update of treatment options
por: Busse, Laurence W., et al.
Publicado: (2020)

Definitions and pathophysiology of vasoplegic shock
por: Lambden, Simon, et al.
Publicado: (2018)

Vasoplegic Syndrome after Cardiopulmonary Bypass in Cardiovascular Surgery: Pathophysiology and Management in Critical Care
por: Ltaief, Zied, et al.
Publicado: (2022)

Complexities of Characterizing “Vasoplegics”
por: Niyogi, Subhrashis Guha, et al.
Publicado: (2023)

Methylene Blue for Vasoplegic Syndrome Postcardiac Surgery
por: Habib, Aly Makram, et al.
Publicado: (2018)

Reply to: Complexities of Characterizing Vasoplegics
por: Magoon, Rohan, et al.
Publicado: (2023)

Methylene Blue For Post-Cardioplumonary Bypass Vasoplegic Syndrome
por: Pangasa, Neha, et al.
Publicado: (2017)

Comment: update on the management of constipation in the elderly: new treatment options
por: Techner, Lee
Publicado: (2010)

Vasoplegic Syndrome after Cardiac Surgery for Infective Endocarditis
por: Lim, Pascal, et al.
Publicado: (2022)

Twenty years of vasoplegic syndrome treatment in heart surgery. Methylene blue revised
por: Evora, Paulo Roberto Barbosa, et al.
Publicado: (2015)

Vasoplegic syndrome in patients undergoing heart transplantation
por: Qin, Tong-xin, et al.
Publicado: (2023)

Vasoplegic Syndrome and Anaesthesia: A Narrative Review
por: Gökdemir, Begüm Nemika, et al.
Publicado: (2023)

Ketamine, Interleukin-6, and Vasoplegia: Is Prevention the Best Medicine?
por: Ortoleva, Jamel P.
Publicado: (2023)

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?
por: Bendjelid, Karim
Publicado: (2020)

HOW MUCH CARDIOTHORACIC SURGERY IS TAUGHT IN UK MEDICAL SCHOOLS?
por: Chan, Jeremy, et al.
Publicado: (2019)

Normalizing the Abnormal: Hypoxemia in Venovenous ECMO
por: Ortoleva, Jamel P., et al.
Publicado: (2022)

Very High Dose Epinephrine for the Treatment of Vasoplegic Syndrome during Liver Transplantation
por: Khosravi, M. B., et al.
Publicado: (2013)

Comments on the Pathophysiological Basis and Rationale for Early Treatment of COVID-19
por: Weissmann, Leonardo, et al.
Publicado: (2021)

The Use of Intravenous Hydroxocobalamin as a Rescue in Methylene Blue-resistant Vasoplegic Syndrome in Cardiac Surgery
por: Cai, Yi, et al.
Publicado: (2017)

Nonocclusive mesenteric ischemia following cardiothoracic surgery
por: Kiyonaga, N, et al.
Publicado: (2010)

Outcomes Following the Use of Angiotensin II in Patients with Postoperative Vasoplegic Syndrome: A Case Series
por: Konkol, Samuel B., et al.
Publicado: (2022)

Comment on the article: “Microvascular effects of intravenous esmolol in patients with normal cardiac function undergoing postoperative atrial fibrillation: a prospective pilot study in cardiothoracic surgery”
por: Zheng, Ye Ying, et al.
Publicado: (2019)

Nonopioid Analgesics for Managing Postoperative Pain after Cardiothoracic Surgeries
por: Nair, Abhijit S
Publicado: (2019)

Non-technical skills for surgeons: challenges and opportunities for cardiothoracic surgery
por: Vervoort, Dominique, et al.
Publicado: (2020)

Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options
por: Elwir, Saleh, et al.
Publicado: (2017)

Methylene Blue for Postcardiopulmonary Bypass Vasoplegic Syndrome: A Cohort Study
por: Mazzeffi, Michael, et al.
Publicado: (2017)

The use of hydroxocobalamin for vasoplegic syndrome in left ventricular assist device patients
por: Ayers, Brian, et al.
Publicado: (2020)

Use of methylene blue in vasoplegic syndrome that developed during non-cardiac surgery - A case report -
por: Oh, In Duk, et al.
Publicado: (2019)

Cardiothoracic Surgery in the Caribbean
por: Vinck, Eric E., et al.
Publicado: (2021)

Vasopressin in vasoplegic shock: A systematic review
por: Webb, Andrew J, et al.
Publicado: (2020)

Vasopressin versus norepinephrine infusion in patients with vasoplegic shock after cardiac surgery
por: Hajjar, L, et al.
Publicado: (2009)

Comparison of cardiothoracic surgery training in usa and germany
por: Tchantchaleishvili, Vakhtang, et al.
Publicado: (2010)

Why Methylene Blue Is the Only Option for Blocking the cGMP/NO Pathway in The Treatment of Vasoplegic Shock? “Reasons That Reason Itself Does Not Know...”
por: Evora, Paulo Roberto B., et al.
Publicado: (2021)

High-dose hydroxocobalamin for vasoplegic syndrome causing false blood leak alarm
por: Cheungpasitporn, Wisit, et al.
Publicado: (2017)

Longer term hemodialysis-dependent chronic renal failure increases the risk of post-cardiac surgery vasoplegic syndrome
por: Suga, Masafumi, et al.
Publicado: (2020)

The additional use of methylene blue has a decatecholaminisation effect on cardiac vasoplegic syndrome after cardiac surgery
por: Petermichl, Walter, et al.
Publicado: (2021)

The status of cardiothoracic surgery trainee education and recruitment: An update one year into the coronavirus disease 2019 (COVID-19) pandemic
por: Olive, Jacqueline K., et al.
Publicado: (2021)

Carcinoid syndrome: update on the pathophysiology and treatment
por: de Celis Ferrari, Anezka C. Rubin, et al.
Publicado: (2018)

An Update on the Pathophysiology and Treatment of Cardiorenal Syndrome
por: Raina, Rupesh, et al.
Publicado: (2020)

In response to: Non opioid Analgesics for Managing Postoperative Pain after Cardiothoracic Surgeries
por: Nachiyunde, Brenda Saboi Lupindula, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1pfjn2vr3j594i2qh638ub7d52